Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T08:58:58.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T04:58:39.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Results posting details were added: Results First Submitted (2026-01-05), Results First Posted with QC Comments (2026-01-22), Results First Posted (2026-02-10), and associated PDFs such as the Study Protocol and Informed Consent Form.
    Difference
    3%
    Check dated 2026-02-11T16:22:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A site-wide notice about the lapse in government funding and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:44:28.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Introduces a glossary toggle and updates metadata labels (Last Update Submitted that Met QC Criteria and Last Update Posted) along with the revision to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T06:24:32.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision label on the page updated from `Revision: v3.3.3` to `Revision: v3.3.4`.
    Difference
    0.1%
    Check dated 2026-01-14T02:29:03.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.